4
Changes in Ownership
Spyre Therapeutics, Inc. Filed Acc 0000950170-24-061084
Options or other derivatives
- Director acquired 22,646 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Fairmount Funds Management LLC · Director
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-05-14 | Grant or award : show line 1 in the form Stock Option (Right to Buy) | +11,323 | 11,323 | I |
| 2024-05-14 | Grant or award : show line 2 in the form Stock Option (Right to Buy) | +11,323 | 11,323 | I |
Loading xslF345X05/ownership.xml…